Related Experiment Video
Updated: Jul 5, 2026
11:00
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
[Ten questions about cardiac sarcoidosis]
Giuseppe Ciliberti1, Stefano Cangemi2, Francesca Musella3
1SOD Clinica di Cardiologia e Aritmologia, Centro Cardiovascolare di Alta Specializzazione del Medio Adriatico "Lancisi", Azienda Ospedaliero Universitaria delle Marche, Ancona.
Giornale Italiano Di Cardiologia (2006)
|March 25, 2026
Summary
Cardiac sarcoidosis, a rare heart condition, involves granulomas in the heart muscle. Early diagnosis and immunosuppressive therapy are key to managing inflammation and preventing sudden cardiac death.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Cardiac sarcoidosis is a rare, life-threatening condition involving myocardial granulomas.
- Manifestations vary from asymptomatic to severe heart failure and sudden cardiac death.
Purpose of the Study:
- To provide a comprehensive overview of cardiac sarcoidosis.
- To address epidemiology, diagnosis, treatment, and risk stratification based on current guidelines.
Main Methods:
- Multimodality diagnostic approach including advanced imaging and histology.
- Review of international guidelines and consensus documents.
- Structured Q&A format covering ten clinical questions.
Main Results:
- Diagnosis requires integrated clinical, imaging, and histological data.
- Immunosuppressive therapy is the primary treatment for myocardial inflammation.
- Risk stratification for sudden cardiac death is critical, with ICDs for selected patients.
Conclusions:
- Early recognition and prompt treatment are vital for managing cardiac sarcoidosis.
- A multidisciplinary approach optimizes patient outcomes.
- Adherence to updated guidelines improves care for this rare condition.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...